March 10-11, 2019 | Moscone South Convention Center

Cambridge Healthtech Institute is pleased to offer short courses taking place on Sunday and Monday at the Moscone South Convention Center. The short courses are designed to be instructional, interactive and provide in-depth information on a specific topic. They allow for one-on-one interaction and provide a great way to explain more technical aspects that would otherwise not be covered during the main conference programs that take place Monday-Wednesday or symposia and training seminars that take place Thursday-Friday.

SUNDAY, MARCH 10, 2:00 - 5:00 PM (AFTERNOON SHORT COURSES)

SC1: Precision Medicine 101: Genomic Literacy, Medical Applications, Risk and Regulation

Jeanette McCarthy, MPH, PhD, Adjunct Associate Professor, Duke University; Founder, Precision Medicine Advisors

SC2: Coverage and Reimbursement for Advanced Diagnostics

Kurt Matthes, Vice President, RCM Reengineering and Service, Revenue Cycle Management, TELCOR, Inc.

Becky Foster, Principal, Foster Health Care Consulting

SC3: NGS Assay Selection, Validation and Compliance

Birgit Funke, PhD, FACMG, Vice President, Clinical Affairs, Veritas Genetics; Associate Professor of Pathology, Harvard Medical School (AMP Genetics Subdivision Chair and Representative to the AMP 2018 Board of Directors; Member)

Karl Voelkerding, MD, Professor of Pathology, University of Utah School of Medicine (AMP Member)

Avni Santani, PhD, Director, Genomic Diagnostics, Children’s Hospital of Philadelphia (AMP Member)

SC4: Translating CTCs and ctDNA for Clinical Use

Sonya Parpart-Li, PhD, Senior Research Scientist, Memorial Sloan Kettering Cancer Center

Gozde Durmus, PhD, Postdoctoral Research Fellow, Stanford Genome Technology Center, Department of Biochemistry, Stanford University School of Medicine

Prachi Kothari, DO, Instructor, Department of Pediatrics, Memorial Sloan Kettering Cancer Center

SC5: Tissue Print Technologies for Molecular Biomarker Studies

Sandra M. Gaston, PhD, Director, Molecular Biomarkers Research Laboratory, Pathology and Laboratory Medicine, Tufts Medical Center; Assistant Professor, Anatomic and Clinical Pathology, Tufts University School of Medicine; Director, Urological Research, New England Baptist Hospital

SC6: Data Visualization

Nils Gehlenborg, PhD, Assistant Professor, Department of Biomedical Informatics, Harvard Medical School

SC7: Omic Technology for Cancer Immunology

Kellie Smith, PhD, Instructor of Oncology, Johns Hopkins

Additional Instructors to be Announced

SC8: Data-Driven Process Development in the Clinical Laboratory

Robert Young, CGMBS, MS Bioinformatics, Owner and Principal Consultant, Lab Insights, LLC

SUNDAY, MARCH 10, 5:30 - 8:30 PM (DINNER SHORT COURSES)

SC9: Mastering Variant Interpretation

Jeanette McCarthy, MPH, PhD, Adjunct Associate Professor, Duke University; Founder, Precision Medicine Advisors

SC10: Regulatory Compliance in Molecular Diagnostics

Melina Cimler, PhD, CEO & Founder, PandiaDx

Pamela Swatkowski, President, Regulatory Affairs & Compliance, PLS Consulting, LLC

Morteza Minaee, LPD, RAC, Vice President, Regulatory Affairs, Guardant Health, Inc. 

SC11: Companion Diagnostics for Immuno-Oncology

Kenneth Emancipator, MD, DABP, Executive Medical Director and Head of Companion Diagnostics, Merck & Co., Inc.

Mary J. Savage, Scientific Director, Companion Diagnostics, Merck & Co., Inc.

Deepti Aurora-Garg, Director, Companion Diagnostics, Merck & Co., Inc.

SC12: Clinical Informatics: Returning Results from Big Data

Mark Routbort, MD, PhD, Director, Computational and Integrational Pathology; Associate Professor, Hematopathology; Medical Director, Laboratory Informatics, UT MD Anderson Cancer Center (AMP Informatics Subdivision Representative to the AMP 2017 Clinical Practice Committee; Member)

Somak Roy, MD, Director, Molecular Informatics, Genetics Services, & MGP Fellowship, Molecular and Genomic Pathology, University of Pittsburgh Medical Center (AMP Member)

SC13: Microfluidics and Lab-on-a-Chip Devices for POCT: Technologies and Commercialization

Chris Myatt, Founder & CEO, MBio Diagnostics, Inc.

Additional Instructors to be Announced

SC14: Liquid Biopsy Technologies and Applications

John Simmons, PhD, Director, Translational Science & Diagnostics, Personal Genome Diagnostics

Hatim Husain, MD, Physician, Medical Oncology, University of California, San Diego

SC15: Development of Bioassays for Checkpoint Immunotherapy

Sofie Pattijn, CTO, ImmunXperts

SC16: Applications of Artificial Intelligence in Drug Discovery & Development

Arvind Rao, PhD, Associate Professor, Department of Computational Medicine and Bioinformatics, University of Michigan

Additional Instructors to be Announced

MONDAY, MARCH 11, 8:00 - 11:00 AM (MORNING SHORT COURSES)

SC17: Next-Generation Sequencing as a Diagnostics Platform

Madhuri Hegde, PhD, FACMG, Professor, Human Genetics; Executive Director, Emory Genetics Laboratory, Emory University School of Medicine

Birgit Funke, PhD, FACMG, Vice President, Clinical Affairs, Veritas Genetics; Associate Professor of Pathology, Harvard Medical School (AMP Genetics Subdivision Chair and Representative to the AMP 2018 Board of Directors; Member)

Additional Instructors to be Announced

SC18: Commercialization Boot Camp: Manual for Success in Molecular Diagnostics

Harry Glorikian, MBA, Healthcare Consultant

Stan Skrzypczak, MBA, Vice President, Corporate Development and Reimbursement, Guardant Health, Inc.

SC19: NGS for Infectious Disease Diagnostics

Charles Chiu, MD, PhD, Associate Professor, Lab Medicine and Infectious Diseases; Director, UCSF-Abbott Viral Diagnostics and Discovery Center; Associate Director, Clinical Microbiology Laboratory, University of California, San Francisco

SC20: Digital Pathology: A-Z for Beginners

Matthew G. Hanna, MD, Clinical Instructor, Breast and Informatics, Department of Pathology, Memorial Sloan Kettering Cancer Center

SC21: Detection and Characterization of Circulating Biomarkers

Catherine Alix-Panabières, PhD, Director, Laboratory of Rare Human Circulating Cells (LCCRH), Pathology and Onco-Biology Department, University Medical Center of Montpellier, France

Klaus Pantel, MD, Professor and Founding Director, Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, University of Hamburg, Germany

SC22: Cellular Phenotyping Assays in Oncology Trials

Nathan Standifer, PhD, Senior Scientist, Clinical Pharmacology and DMPK, MedImmune

Mark Edinger, Scientific Affairs Director, Flow Cytometry, Q2 Solutions

Linlin Xu, PhD, Scientist I, Clinical Pharmacology and DMPK, MedImmune

Megan McCausland, Senior Scientist, Translation Science Laboratory, Q2 Solutions

SC23: Best Practices in Personalized and Translational Medicine

Susan Mockus, PhD, MBA, Associate Director, Clinical Genomic Market Development, The Jackson Laboratory for Genomic Medicine

Alex Sherman, Director, Center for Innovation and Bioinformatics, Neurological Clinical Research Institute, Massachusetts General Hospital; Principal Associate in Neurology, Harvard Medical School

Additional Instructors to be Announced

SC24: Connected Diagnostics: IoT, Sensors and Wearables Bring Point-of-Care Dx to the Patient

Wasim Malik, PhD, Chief Digital Strategist, Roivant Sciences; Assistant Professor, Harvard Medical School

Chris Van Hoof, Senior Director, Connected Health Solutions, imec

Additional Instructors to be Announced

* The program is subject to change without notice, due to unforeseen reason.

Choose your language
Japanese
Traditional Chinese
Simplified Chinese
Korean